| Position | Action |
|---|---|
| ORCL underweight thesis active | Trim 20-25% of current ORCL position |
| Post-trim state | Target 65-75% of benchmark weight |
| FCF trajectory deepens negative | Additional 5% trim |
| Rating agency negative outlook revision | Immediate additional 5% trim |
Oracle's fundamental execution (17-20% revenue growth, record margins, $32B OCF) is being overshadowed by macro AI-debt anxiety, creating an asymmetric risk/reward where the stock at $147 with a PEG of 0.82 and ~67-94% upside to targets is a high-conviction BUY.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $137.49 | bullish |
| 50 SMA | $159.92 | bearish |
| 200 SMA | $178.20 | bearish |
| RSI (14) | 56.68 | neutral |
| MACD Line | -2.42 | bullish |
| MACD Signal Line | -7.25 | bullish |
| MACD Histogram | +4.83 | bullish |
| Bollinger Upper Band | $149.49 | bearish |
| Bollinger Middle | $129.47 | neutral |
| Bollinger Lower Band | $109.45 | bearish |
| ATR (14) | $7.59 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Underweight ORCL: Trim 20-25%, hedge with ITM puts, two-tier stop discipline
Underweight with disciplined trimming, intelligent hedging, and two-tier stops. The operational story prevents a Sell; the capital structure prevents a Buy. The right call acknowledges both forces and reduces exposure to a level where either outcome can be absorbed without portfolio damage. Re-evaluate to Hold if price establishes base above $180 with volume OR FCF turns positive on TTM basis; return to Overweight only if all three re-entry criteria are met and Q1 FY27 shows capex discipline.
When: Trailing 4-quarter FCF turns positive
Then: Re-entry eligible (1 of 3)
Valuation is compelling—the market is not paying a premium for this growth trajectory
↩ rebuts: “Bear claim that stock is fairly or appropriately priced given credit concerns”
· concedes: Single-customer (OpenAI) concentration risk is real and worth monitoring; Capex of $50B+ is enormous and requires continued revenue validation; Stock is in a confirmed downtrend with price below 50 SMA ($159.92) and 200 SMA ($178.20); Higher-for-longer rates do raise cost of capital for debt-funded buildout; The rally could be a dead cat bounce if MACD fails to hold
Oracle's growth story is a "capex mirage" — revenue growth is purchased with debt rather than earned through capital efficiency, with the company burning $23.7B in free cash flow annually while running 82.6% capex/revenue ratio versus 25-35% for hyperscaler peers, creating structural vulnerability to credit stress, OpenAI concentration, and a tightening macro environment that makes the "flawless multi-year execution" required for the bull case a "high-conviction hope" rather than a high-conviction long.
· concedes: Capital efficiency concerns are legitimate — the 82.6% capex/revenue ratio is a real number; Debt-fueled growth does deserve scrutiny — the $40.2B in new debt is a fact; The technical setup shows the stock below key moving averages — price is $12.90 below the 50 SMA and $31.18 below the 200 SMA; Some earnings power assumptions may be achievable — the EPS jump to $10.89 is a consensus target, not impossible
→ vs conservative: Holding ignores a 67% drawdown on a deteriorating balance sheet; the 'great business unfairly punished' thesis has no downside protection when free cash flow is negative $23.7B and the company depends on capital markets staying open
→ vs neutral: Technical 'bottom' signals (RSI recovery, MACD bullish) are being interpreted as buying opportunities when volume is exhausted and price hasn't even reclaimed the 50 SMA; calling this a bottom is premature and dangerous
| bearish |
| VWMA (30-day) | $129.31 | neutral |
Support: 137.49 · 129.47 · 114.99 · 109.45 | Resistance: 149.49 · 159.92 · 178.2
Bearish alignment intact with 10 < 50 < 200 moving average structure. MACD has generated a bullish crossover but remains below zero (bearish regime). RSI at 56.68 recovered from deeply oversold conditions. Price at $147.02 is hugging the upper Bollinger Band at $149.49, indicating stretched short-term conditions. Volume is declining into the rally (yellow flag), averaging 50M+ shares/day during the sell climax (Jul 13-16) versus 49.7M→43.7M→23.5M→23.1M→17.5M during the bounce (Aug 3-7). ATR of $7.59 represents extreme volatility (~5.2% daily range). The overall bias is bearish with a counter-trend bounce in progress; HOLD recommendation maintained with trailing stops at 10 EMA ($137.49).
Market Capitalization
$423.5B
Enterprise Value
~$521.7B
Share Price
~$147.04
TTM Revenue
$67.36B
TTM Gross Profit
$44.34B
TTM Gross Margin
65.8%
TTM EBITDA
$30.49B
TTM EBITDA Margin
49.7%
TTM Net Income
$16.98B
TTM EPS (Diluted)
$5.82
Forward EPS
$10.89
Operating Margin (TTM)
36.2%
Profit Margin (TTM)
25.4%
Return on Equity
53.4%
Return on Assets
6.5%
Free Cash Flow (TTM)
-$24.5B
Operating Cash Flow
$31.98B
Capital Expenditure
-$55.66B
Beta (Volatility)
1.72
52-Week Range Low
$114.50
52-Week Range High
$345.72
50-Day Moving Average
$163.99
200-Day Moving Average
$182.34
Dividend Yield
1.39%
Trailing P/E
25.3x
Forward P/E
13.5x
PEG Ratio
0.82
P/B Ratio
11.27x
Debt/Equity
388.87%
Total Debt
$156.2B
Net Debt
$98.3B
Cash & Equivalents
$31.3B
Stockholders' Equity
$42.51B
Tangible Book Value
-$19.8B
Net PPE (Data Centers)
$129.6B
Goodwill
$62.3B
Preferred Stock
$4.95B
FY2026 Revenue Growth
+17.4%
FY2026 Net Income Growth
+37.4%
FY2026 Diluted EPS
$5.83
FY2026 Operating Margin
33.3%
FY2026 Net Margin
25.4%
FY2025 Revenue
$57.40B
FY2024 Revenue
$52.96B
FY2023 Revenue
$49.95B
Q4 FY26 Revenue
$19.18B
Q4 FY26 Net Income
$4.30B
Q4 FY26 Diluted EPS
$1.45
Q4 FY26 Operating Income
$6.96B
Q4 FY26 Operating Margin
36.3%
Interest Coverage Ratio
5x
Interest Expense
$4.6B
EBIT
$24.2B
Stock-Based Compensation
$4.8B
Construction in Progress
$39.97B
Strengths
Concerns
Oracle is undergoing the most aggressive capital investment cycle in its history, deploying $55.7B in annual capex to build hyperscale data centers for cloud/AI infrastructure, which has driven free cash flow deeply negative and elevated debt to $156.2B. Despite this, FY26 results validate the investment thesis with revenue acceleration to 17.4% growth and record profitability (33.3% operating margin, 25.4% net margin), with Q4 FY26 posting the company's largest quarterly revenue ever at $19.18B. The valuation disconnect between trailing P/E (25.3x) and forward P/E (13.5x) suggests the market is pricing in significant EPS growth to $10.89, which would justify current levels if infrastructure investments monetize as expected.